FDA approves Teva once-monthly injectable schizophrenia drug Weltruza
Teva said the FDA approved its once-monthly injectable schizophrenia treatment Weltruza, formerly called olanzapine. The company said it is the first once-a-month under-the-skin shot for the condition.